EUVIMEDEUVIMED entdecken
Open Access

LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5

Zhiqiang Wu, Xiaofei Zeng, Hong Wang, Xianbo Wang

Cancer Biomarkers · 2023

DOI: 10.3233/cbm-220223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2023. Verfasst von Zhiqiang Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracardiac Surgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Adenocarcinoma of Lung, Antigens, CD. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: It has been discovered that lncRNA ARAP1-AS1 is upregulated and operates as a tumor promoter in many cancers. However, its pattern of expression and potential mechanism in lung adenocarcinoma (LUAD) is still unknown. METHODS: The levels of lncRNA ARAP1-AS1, miR-8068, and CEACAM5 expressions in LUAD cell lines and tissues were assessed by conducting western blot and RT-qPCR analyses. MiR-8068’s potential targeting relationships with lncRNA ARAP1-AS1 and CEACAM5 were ascertained by performing bioinformatics analysis. The interaction of lncRNA ARAP1-AS1 with miR-8068 was validated by means of by RIP and luciferase reporter experiments. CCK-8, cell adhesion, and Transwell migration experiments were conducted to study how lncRNA ARAP1-AS1 affects LUAD cell migration, adhesion, and proliferation. To confirm the function of lncRNA ARAP1-AS1 in vivo, a tumor formation experiment was executed. RESULTS: An elevated expression of lncRNA ARAP1-AS1 was observed among the LUAD cells and tissues. The overexpression of lncRNA ARAP1-AS boosted cell proliferation, adhesion, and migration in LUAD and also favored in vivo tumor growth. MiR-8068 was found to be lncRNA ARAP1-AS1’s target gene. MiR-8068 overexpression partially antagonized lncRNA ARAP1-AS1’s promotive effect on proliferation, viability, and adhesion. Meanwhile CEACAM5 could alleviate the miR-8068-induced inhibition of tumor growth. The negative correlation of miR-8068 with lncRNA ARAP1-AS1 or CEACAM5 was also revealed. CONCLUSION: To upregulate CEACAM5 expression lncRNA ARAP1-AS1 targeted miR-8068, thus promoting the progression of LUAD. This indicates that the lncRNA ARAP1-AS1/miR-8068/CEACAM5 axis has potential as a therapeutic target in LUAD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRNA, Long NoncodingAdenocarcinoma of LungAntigens, CDLung NeoplasmsHumansAnimalsGene Expression Regulation, NeoplasticMiceCell ProliferationGPI-Linked ProteinsCell MovementCell Line, TumorFemaleUp-RegulationMaleCell AdhesionMice, NudeCarcinoembryonic Antigen

Stichwörter der Autor:innen

ARAP1-AS1CEACAM5lung adenocarcinomamiR-8068

Substanzen

MicroRNAsRNA, Long NoncodingGPI-Linked ProteinsCEACAM5 protein, humanAntigens, CDCarcinoembryonic Antigen

Autor:innen und Institutionen

  • Department of Thoracardiac Surgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
  • Department of Thoracic surgery, Ya'an City Second People's Hospital, Ya'an, Sichuan, China.

Zitieren

APA

Wu, Z., Zeng, X., Wang, H., & Wang, X. (2023). LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5. Cancer Biomarkers. https://doi.org/10.3233/cbm-220223

Vancouver

Wu Z, Zeng X, Wang H, Wang X. LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5. Cancer Biomarkers. 2023. doi:10.3233/cbm-220223

BibTeX
@article{Wu2023,
  author = {Wu, Zhiqiang and Zeng, Xiaofei and Wang, Hong and Wang, Xianbo},
  title = {LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5},
  journal = {Cancer Biomarkers},
  year = {2023},
  doi = {10.3233/cbm-220223}
}
Kostenlos starten →